Ligand validation:7CI9

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7CI9_EDO_A_1302	91%	93%	0.087	0.974	0.23	0.24	-	-	0	0	100%	1
7CI9_EDO_A_1303	67%	98%	0.118	0.927	0.13	0.14	-	-	0	0	100%	1
7CI9_EDO_A_1304	67%	98%	0.151	0.96	0.11	0.15	-	-	0	0	100%	1
7CI9_EDO_A_1307	66%	99%	0.124	0.928	0.08	0.14	-	-	1	0	100%	1
7CI9_EDO_A_1305	66%	92%	0.144	0.948	0.25	0.27	-	-	0	0	100%	1
7CI9_EDO_A_1306	55%	95%	0.148	0.917	0.2	0.2	-	-	0	0	100%	1
6CAX_EDO_A_408	93%	82%	0.081	0.976	0.4	0.4	-	-	0	0	100%	0.69
6ANS_EDO_A_404	100%	89%	0.029	0.995	0.57	0.07	-	-	0	0	100%	1
4ITB_EDO_A_503	100%	88%	0.028	0.99	0.38	0.29	-	-	0	0	100%	1
4FQI_EDO_A_401	100%	85%	0.032	0.992	0.46	0.29	-	-	0	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
8JK3_EDO_A_304	100%	81%	0.033	0.992	0.22	0.58	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.